Table IV-BPatient Characteristics

StudyAge/Menopausal StatusRace (%)Disease StageDisease StaqePerformance StatusComorbidities or Other Prognostic Factors
Gasparini et al. 2007Grp1Grp2Grp1Grp2Grp1Grp2Grp1Grp2ScaleGrp1Grp2Grp13rp2
mnBI# met sitesECOGE-/P-31.749.2
md54.2756.02WIIa133.439.7081.780.9E+/P+36.736.5
rng30–7132–72HIIb240.033.3113.412.8E+/P-16.74.8
sdAIIIa313.314.324.96.3E-/P+-10.04.8
OIIIb48.37.9E+/P?1.7
pre31.733.2IV>45.04.8??3.34.8
post68.366.8
Im et al. 2005Grp1Grp1Grp1Grp1ScaleGrp1
mnBI# involved organsECOG
md49WIIa143.6020.5
rng35–70HIIb230.8153.8
sdAIIIa≥325.6225.6
OIIIb
pre41.0IV100
post58.9
Fornier et al. 2005Grp1Grp1Grp1Grp1KPSGrp1
mnBI# met sitesmd90
md51WIIamd2rng70–100
rng33–67HIIbrng1–4
sdAIIIa
OIIIb
preIV100
post
Muller et al. 2004Grp1+2Grp1+2Grp1+2Grp1+2ScaleGrp1+2Grp1+2
mnBIvisc80E+61
md56WIladis
rng33–73HIIb
sdAIIIa
OIIIb
preIV100
post
Luftner et al. 2004Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mn48BI# involved organsE+/P+34%
mdWIIa126E-&P-17
rng31–63HIIb231?49
sdAIIIa>243
OIIIb
pre9IV100
post91
7280, Sandri et al. 2004Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mn56BI# involved organs
mdWIIa125.6
rng36–81HIIb238.6
sd11AIIIa≥335.8
OIIIb
preIV100
post
7960, Colomer et al. 2004Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mnBI# met sitesE+49
md53WIIamd3md100E-28
rng29–72HIIbrng1–6rng70–100?23
sdAIIIa
OIIIb
preIV100
post
9100, Burstein et al. 2003Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mnBI# met sitesECOGE+P+37
md54.5WIIamd3070E+/P-11
rng29–82HIIbrng1–6128E-/P+7
sdAIIIa22E-/P-44
OIIIb
preIV100
post
9520, Lipton et al. 2003Grp1Grp2Grp1Grp2Grp1Grp2Grp1Grp2ScaleGrp1Grp2Grp1Grp2
mnBI1213# met sitesKPSE+&P+3840
md6563W9597Iia221815355md9090E+/P+2827
rng42–9431–90HIib131523734rng50-50-E?/P?3433
sdAIIIa7631011100100
OIIIb812
preIV3028
post?78
Esteva et al. 2002Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mnBI# met sitesKPS(%)
md45WIIa1169063
rng33–78HIIb2408020
sdAIIIa3167016
OIIIb≥426
preIV100
post
Colomer et al. 2000Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mnBI# met sitesE+66.7
mdWIIa155.2E-33.3
rngHIIb≥244.8
sdAIIIa
OIIIb
pre34.5IV100
post65.5
Colomer et al. 2006Grp1Grp1Grp1Grp1ScaleGrp1Grp1
mnBI# met sitesECOGE+67.3
md64WIIamd2041.2E-32.7
rng34–81HIIbrng1–4147.1
sdAIIIa211.8
OIIIb
preIV100
post
Yamauchi et al. 1997Grp1+2+3Grp1+2+3Grp1+2+3Grp1+2+3ScaleGrp1+2+3Grp1+2+3
<6446.8BI# met sitesE++26.7
≥6453.2WIIa144.7E+28.7
HIIb237.2P++20.2
preAIIIa≥318.1P+13.8
postOIIIb
IV100

From: Appendix C. Evidence Data Abstraction Tables

Cover of HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors
HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors.
Evidence Reports/Technology Assessments, No. 172.
Seidenfeld J, Samson DJ, Rothenberg BM, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.